Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16665326
[patent_doc_number] => 10934561
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-02
[patent_title] => Methods and products for increasing CFTR
[patent_app_type] => utility
[patent_app_number] => 15/796414
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3171
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796414 | Methods and products for increasing CFTR | Oct 26, 2017 | Issued |
Array
(
[id] => 16328678
[patent_doc_number] => 20200299644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 15/751440
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751440 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Oct 25, 2017 | Issued |
Array
(
[id] => 12790744
[patent_doc_number] => 20180155417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => MULTIMERIC CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 15/785775
[patent_app_country] => US
[patent_app_date] => 2017-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785775 | MULTIMERIC CONSTRUCTS | Oct 16, 2017 | Abandoned |
Array
(
[id] => 13369035
[patent_doc_number] => 20180236058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => REVERSE GENETICS SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 15/784575
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/784575 | Reverse genetics systems | Oct 15, 2017 | Issued |
Array
(
[id] => 14261765
[patent_doc_number] => 10280435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Gene therapy methods
[patent_app_type] => utility
[patent_app_number] => 15/728381
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 32217
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15728381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/728381 | Gene therapy methods | Oct 8, 2017 | Issued |
Array
(
[id] => 16215365
[patent_doc_number] => 10731165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => RNA hydrogels
[patent_app_type] => utility
[patent_app_number] => 15/727043
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 6760
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727043
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/727043 | RNA hydrogels | Oct 5, 2017 | Issued |
Array
(
[id] => 13168361
[patent_doc_number] => 10100285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Ex vivo proliferation of epithelial cells
[patent_app_type] => utility
[patent_app_number] => 15/722327
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 59
[patent_no_of_words] => 51472
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/722327 | Ex vivo proliferation of epithelial cells | Oct 1, 2017 | Issued |
Array
(
[id] => 12177318
[patent_doc_number] => 20180036254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES'
[patent_app_type] => utility
[patent_app_number] => 15/721501
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14699
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721501 | RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules | Sep 28, 2017 | Issued |
Array
(
[id] => 14649543
[patent_doc_number] => 20190231900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => ADENOASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSES
[patent_app_type] => utility
[patent_app_number] => 16/337953
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337953 | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | Sep 21, 2017 | Issued |
Array
(
[id] => 12217422
[patent_doc_number] => 20180055781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'THERAPEUTIC NANOPARTICLES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/699796
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21968
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699796
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699796 | Therapeutic nanoparticles and methods of use thereof | Sep 7, 2017 | Issued |
Array
(
[id] => 16533320
[patent_doc_number] => 10875904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Enhanced affinity T cell receptors and methods for making the same
[patent_app_type] => utility
[patent_app_number] => 15/692846
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 13575
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692846 | Enhanced affinity T cell receptors and methods for making the same | Aug 30, 2017 | Issued |
Array
(
[id] => 12642012
[patent_doc_number] => 20180105835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => TARGETED RNA KNOCKDOWN AND KNOCKOUT BY TYPE III-A Csm COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/692866
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692866
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692866 | Targeted RNA knockdown and knockout by type III-A Csm complexes | Aug 30, 2017 | Issued |
Array
(
[id] => 14326973
[patent_doc_number] => 10294491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
[patent_app_type] => utility
[patent_app_number] => 15/687835
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10393
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687835 | Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences | Aug 27, 2017 | Issued |
Array
(
[id] => 12217524
[patent_doc_number] => 20180055884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'CELL SUSPENSION FOR USE IN THE TREATMENT OF LOWER EXTREMITY PERIPHERAL ARTERY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/688555
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17164
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688555 | Cell suspension for use in the treatment of lower extremity peripheral artery disease | Aug 27, 2017 | Issued |
Array
(
[id] => 12388320
[patent_doc_number] => 09963680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Ex vivo proliferation of epithelial cells
[patent_app_type] => utility
[patent_app_number] => 15/685853
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 43915
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685853
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685853 | Ex vivo proliferation of epithelial cells | Aug 23, 2017 | Issued |
Array
(
[id] => 14468443
[patent_doc_number] => 20190185864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 16/327396
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327396 | COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT | Aug 22, 2017 | Abandoned |
Array
(
[id] => 14820969
[patent_doc_number] => 10407476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Methods and compositions for treating hemophilia
[patent_app_type] => utility
[patent_app_number] => 15/673163
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 22163
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673163 | Methods and compositions for treating hemophilia | Aug 8, 2017 | Issued |
Array
(
[id] => 18215271
[patent_doc_number] => 11590184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Oncolytic rhabdovirus expressing IL12
[patent_app_type] => utility
[patent_app_number] => 16/324490
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 40
[patent_no_of_words] => 7398
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324490 | Oncolytic rhabdovirus expressing IL12 | Aug 8, 2017 | Issued |
Array
(
[id] => 12151557
[patent_doc_number] => 20180022821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TUMOR TRANSDUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/670535
[patent_app_country] => US
[patent_app_date] => 2017-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13805
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15670535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/670535 | Compositions and methods for tumor transduction | Aug 6, 2017 | Issued |
Array
(
[id] => 14407617
[patent_doc_number] => 20190169652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CEP290 ASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/322922
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322922
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322922 | Compositions and methods for treating CEP290 associated disease | Aug 1, 2017 | Issued |